English
Home > Products > Lisinopril Dihydrate advance intermediate

China Lisinopril Dihydrate advance intermediate Factory

We believe that prolonged time period partnership is really a result of top of the range, benefit added provider, prosperous knowledge and personal contact for Lisinopril Dihydrate advance intermediate,CAS NO 90315-82-5,90315-82-5,Lisinopril Dihydrate intermediate,Ethyl (R)-2-hydroxy-4-phenylbutyrate, The principle of our business is to present high-quality items, expert support, and truthful communication. Welcome all close friends to place trial buy for developing a long-term business relationship.
Lisinopril Dihydrate advance intermediate, Our company always committed to meet your quality demand, price points and sales target. Warmly welcome you open the boundaries of communication. It is our great pleasure to service you if you want a trusted supplier and value information.

Related Products

Hot Products

  • 3-CHLORO-2,4-DIFLUORONITROBENZENE

    3-CHLORO-2,4-DIFLUORONITROBENZENE

    Product Name:3-CHLORO-2,4-DIFLUORONITROBENZENE
    Molecular Formula:C6H2ClF2NO2
    Molecular Weight:193.54
    CAS Registry Number:3847-58-3
  • Tosufloxacin tosilate

    Tosufloxacin tosilate

    Product Name:Tosufloxacin tosilate
    Molecular Formula:C19H17F3N4O4
    Molecular Weight;422.36
    CAS Registry Number;107097-79-0
  • 9-Bromoanthracene

    9-Bromoanthracene

    Product Name:9-Bromoanthracene
    Molecular Formula:C14H9Br
    Molecular Weight:257.13
    CAS Registry Number:1564-64-3
  • 2-Chloromethyl-3-Methyl-4-Methoxypyridine

    2-Chloromethyl-3-Methyl-4-Methoxypyridine

    Product Name:2-Chloromethyl-3-Methyl-4-Methoxypyridine
    Molecular Formula:C8H10ClNO
    Molecular Weight:171.62
    CAS Registry Number:124473-12-7
  • Avatrombopag

    Avatrombopag

    Product Name:Avatrombopag
    Molecular Formula:C29H34Cl2N6O3S2
    Molecular Weight;649.65
    CAS Registry Number;570406-98-3
  • 20-(tert-Butoxy)-20-oxoicosanoic acid

    20-(tert-Butoxy)-20-oxoicosanoic acid

    Product Name:20-(tert-Butoxy)-20-oxoicosanoic acid
    Molecular Formula:C24H46O4
    Molecular Weight:398.62
    CAS Registry Number:683239-16-9
  • Related Blog
  • Reviews

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • Pharmaceutical Intermediates Manufacturers - Something You Need to Know About Pharma Intermediates Industry

    Pharmaceutical intermediates are actually chemical raw materials or chemical products that need to be used in the synthesis of drugs. Such chemical products can be produced in ordinary chemical plants without obtaining a pharmaceutical production license. As long as the technical indicators meet certain level requirements, they can be used to participate in the synthesis and production of drugs.

  • What are pharmaceutical intermediates?

    Pharmaceutical intermediates are fine chemical products in the production process from pharmaceutical chemical raw materials to bulk drugs or drugs. The synthesis of chemical drugs depends on high-quality pharmaceutical intermediates. This chemical, which does not require a drug production license, can be produced in ordinary chemical plants and can be used in the synthesis of drugs as long as it reaches certain grades.

  • What is the difference between API and FDF in pharma？

    In the pharmaceutical industry, you might hear the terms “FDF” and “API” frequently used in reference to products. We surely understand this type of jargon, but we certainly can see how the general public would feel overwhelmed looking at those kinds of terminology abbreviations. This article is for explaining the difference between API and FDF. For reference, they mean, respectively, “finished dosage form” and “active pharmaceutical ingredient.”

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept